Biotech Acquisition Company Unit

NASDAQ: BIOTU- / - / USA
10.14-0.0200-0.20%Vol 2.50K1Y Perf -1.70%
Apr 15th, 2021 19:50 DELAYED
BID0.00 ASK0.00
Open10.11 Previous Close10.15
Pre-Market- After-Market-
 - -%  - -
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap- 
Earnings Rating
Price Range Ratio 52W %
30.17 
Earnings Date
-

Today's Price Range

10.1010.14

52W Range

9.7910.95

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Neutral
Performance
1 Week
0.70%
1 Month
0.80%
3 Months
-
6 Months
-
1 Year
-1.70%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
BIOTU10.14-0.0200-0.20
AAPL133.78-0.7200-0.54
GOOG2 291.90-4.7600-0.21
MSFT259.21-0.2900-0.11
XOM57.000.02000.04
WFC43.100.86002.04
JNJ161.120.73000.46
FB305.64-2.1800-0.71
GE13.46-0.0900-0.66
JPM153.221.05000.69
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume2.50K
Shares Outstanding0
Trades Count680
Dollar Volume1.88M
Avg. Volume112.43K
Avg. Weekly Volume21.18K
Avg. Monthly Volume40.04K
Avg. Quarterly Volume112.43K

Biotech Acquisition Company Unit (NASDAQ: BIOTU) stock closed at 10.13 per share at the end of the most recent trading day (a -0.2% change compared to the prior day closing price) with a volume of 2.53K shares and market capitalization of 0.0000. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the industry, sector and employs 0 people. Biotech Acquisition Company Unit CEO is .

The one-year performance of Biotech Acquisition Company Unit stock is -1.7%, while year-to-date (YTD) performance is %. BIOTU stock has a five-year performance of %. Its 52-week range is between 9.79 and 10.95, which gives BIOTU stock a 52-week price range ratio of 30.17%

Biotech Acquisition Company Unit currently has a PE ratio of -, a price-to-book (PB) ratio of -, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -5.59%, a ROC of -% and a ROE of -25.00%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Biotech Acquisition Company Unit, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Biotech Acquisition Company Unit’s next earnings report date is -.

The consensus rating of Wall Street analysts for Biotech Acquisition Company Unit is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Biotech Acquisition Company Unit stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Biotech Acquisition Company Unit has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Biotech Acquisition Company Unit has a Neutral technical analysis rating based on Technical Indicators (ADX : 21.98, ATR14 : 0.10, CCI20 : 130.31, Chaikin Money Flow : 0.21, MACD : 0.18, Money Flow Index : 94.68, ROC : 1.40, RSI : 45.55, STOCH (14,3) : 82.35, STOCH RSI : 0.83, UO : 61.62, Williams %R : -17.65), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Biotech Acquisition Company Unit in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Biotech Acquisition Company Unit

CEO:

Telephone:

Address: , , ,

Number of employees: 0

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

67%33%

Bearish Bullish

75%25%

Bearish Bullish

50%50%

Bearish Bullish

75%25%

News

Stocktwits